News Reader
12-25-2008, 04:30 PM
The U.S. Food and Drug Administration today approved Vasovist Injection (gadofosveset trisodium), the first contrast imaging agent for use in patients undergoing magnetic resonance angiography, or MRA, a minimally invasive test for examining blood vessels.
More... (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01934.html)
More... (http://www.fda.gov/bbs/topics/NEWS/2008/NEW01934.html)